Purpose Even if migraine is not fatal, it is a common and challenging disease with adverse
effects on individuals' lives. The lack of objective diagnostic tools causes delays in diagnosis …

Background Calcitonin gene-related peptide (CGRP) has been reported as elevated in
chronic migraine. We aimed to validate the role of interictal serum CGRP concentration in …

Background: Migraine is a prevalent disease with much economic burden and relatively
inadequate available treatment. Calcitonin gene-related peptide (CGRP) is the most …

Although CGRP data must be confirmed and expanded in future studies and specificity of
CGRP levels should be studied in entities able to resemble migraine, it seems that …

Background: During a migraine attack, trigeminal activation results in the release of
calcitonin gene-related peptide (CGRP), which stimulates the release of inflammatory …

Calcitonin gene-related peptide (CGRP) is known to increase during acute attack of
migraine and tension type headache (TTH). However, its concentration during inter-ictal …

Background Several studies have been conducted on the inflammatory aspects of migraine.
Pentraxins are a novel and important part of innate immunity as a superfamily of acute …

Current evidence does not justify the usage of CGRP levels as a biomarker for diagnosing
migraine or for determining the severity of the disease in individual patients. However …

Objectives We investigated the state of inflammation, PTX3 level and other routine
inflammatory markers (high sensitivity C-reactive protein [hsCRP], and white blood cells …

Background Calcitonin gene-related peptide (CGRP) is the most promising candidate to
become the first migraine biomarker. However, literature shows clashing results and …